Columbus VP closes its fourth 150 million fund aimed at developing biotech startups

by Columbus Venture Partners

Columbus Venture Partners (VP) has closed on Tuesday its fourth investment fund with a size of 150 million euros for startups in the biotechnology and pharmaceutical sector, while the total amount of ...

Read more

ARTHEx Biotech, backed by Columbus Venture Partners, receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

by Columbus Venture Partners

ARTHEx Biotech has announced that the U.S. Food and Drug Administration (FDA) cleared the Company to initiate the Phase I-IIa ArthemiR™ study of ATX-01 for the treatment of Myotonic Dystrophy Type 1...

Read more

Quatre Lab, participada por Columbus Venture Partners, adquiere la empresa sueca Vironova BioAnalytics (QuTEM)

by Columbus Venture Partners

Quatre Lab, una empresa vasca especializada en servicios de Control de Calidad para terapias avanzadas y respaldada por Columbus Venture Partners, lidera un sindicato de inversores que incluye a Accor...

Read more

Quatre Lab, backed by Columbus Venture Partners and Grupo SPRI, establishes itself in the Gipuzkoa Science and Technology Park

by Columbus Venture Partners

The investors behind QUATRE LAB include Columbus Venture Partners through its Columbus Life Sciences Fund III and Gestión de Capital Riesgo del País Vasco, SGEIC, S.A. – Grupo SPRI, through its ma...

Read more

ARTHEx Biotech Announces Closing of €42 M Series B Financing led by Columbus Venture Partners to Advance ATX-01, its Novel Treatment for Myotonic Dystrophy Type 1 (DM1)

by Columbus Venture Partners

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs announced the closing of its €42 million Series B financing...

Read more

Columbus Life Sciences Fund IV, with a size of EUR 150 million, has been recently incorporated and accepted by the CNMV

by Columbus Venture Partners

Columbus Life Sciences Fund IV has been recently incorporated and accepted by the CNMV. CVP's fund IV will have a size of EUR 150 million and will follow the same strategy as the previous funds. 10 - ...

Read more

Cocoon Bioscience announces closing of a €15M funding round led by Columbus Venture Partners and Cleon Capital to scale high value proteins production

by Columbus Venture Partners

Cocoon Bioscience’s funding round, led by Columbus Venture Partners and Cleon Capital, will also include several blue-chip co-investors including the Spanish listed company Viscofan, US-based North ...

Read more

Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe

by Columbus Venture Partners

Minoryx is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chies...

Read more

Cleon Capital and Columbus Venture Partners announce the divestment of Spanish biotech company Algenex

by Columbus Venture Partners

The shareholders of Algenex, a privately held biotechnology company backed by a group of families advised by Cleon Capital and leading Spanish biotech fund Columbus Venture Partners, today announced a...

Read more

Integra Therapeutics closes a new investment of €1.5M with the addition of Columbus Venture Partners to seed round

by Columbus Venture Partners

Integra Therapeutics, a biotechnology company that creates next generation gene writing tools, has closed an additional €1.5-million investment from venture capital firm Columbus Venture Partners. T...

Read more

Sanifit Therapeutics será adquirida por la farmacéutica Vifor Pharma

by Columbus Venture Partners

Damià Tormo, Managing Partner de Columbus Venture Partners: “El equipo de Sanifit ha conseguido llevar un proyecto de investigación desde la investigación básica de la Universidad de Islas Balea...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

El fondo Clave Innohealth lidera una ron...

by CLAVE

Clave Capital ha liderado una ronda de inversión de 1,7M de euros en ...

Photos Stream